UF Health now offers drug that might slow Alzheimer’s disease

Lecanemab is thought to successfully target and eliminate clusters of sticky proteins, or amyloid plaques, that form between the brain’s nerve cells and play an important part in the processes that diminish cognitive function wrought by the disease. The medication was approved by the U.S. Food and Drug Administration last year.

Learn more: UF Health now offers drug that might slow Alzheimer’s disease – UF Health

Do you have a loved one diagnosed with Alzheimer’s disease? Explore our Caregiver Support Workshop Series for on-demand videos and resources.